BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11564649)

  • 1. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
    Jones RL; Chan K
    Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the agonist activity of prostacyclin analogues on prostanoid EP4 receptors using GW 627368 and taprostene: evidence for species differences.
    Jones RL; Chan KM
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):289-99. PubMed ID: 15763441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial agonism of taprostene at prostanoid IP receptors in vascular preparations from guinea-pig, rat, and mouse.
    Chan KM; Jones RL
    J Cardiovasc Pharmacol; 2004 Jun; 43(6):795-807. PubMed ID: 15167273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of prostanoid EP receptors by prostacyclin analogues in rabbit iliac artery: implications for anti-restenotic potential.
    McCormick C; Jones RL; Kennedy S; Wadsworth RM
    Eur J Pharmacol; 2010 Sep; 641(2-3):160-7. PubMed ID: 20450909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
    Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
    Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
    Wilson RJ; Giles H
    Br J Pharmacol; 2005 Feb; 144(3):405-15. PubMed ID: 15655509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanisms of enhancement and inhibition of field stimulation responses of guinea-pig vas deferens by prostacyclin analogues.
    Tam FS; Chan K; Borreau JP; Jones RL
    Br J Pharmacol; 1997 Aug; 121(7):1413-21. PubMed ID: 9257922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
    Lawrence RA; Jones RL; Wilson NH
    Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
    Lydford SJ; McKechnie KC; Dougall IG
    Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.
    Rowlands DK; Kao C; Wise H
    Br J Pharmacol; 2001 May; 133(1):13-22. PubMed ID: 11325789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
    Orie NN; Clapp LH
    Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations.
    Jones RL; Wise H; Clark R; Whiting RL; Bley KR
    Br J Pharmacol; 2006 Sep; 149(1):110-20. PubMed ID: 16880763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the EP receptor subtypes mediating relaxation of the rabbit jugular and pig saphenous veins.
    Milne SA; Armstrong RA; Woodward DF
    Prostaglandins; 1995 Apr; 49(4):225-37. PubMed ID: 7667504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
    Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
    Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inhibitory prostanoid receptor in piglet saphenous vein.
    Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
    Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.
    Clarke DL; Giembycz MA; Patel HJ; Belvisi MG
    Br J Pharmacol; 2004 Feb; 141(4):600-9. PubMed ID: 14744812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostanoid receptors involved in the relaxation of human pulmonary vessels.
    Walch L; Labat C; Gascard JP; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 1999 Feb; 126(4):859-66. PubMed ID: 10193765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.